ID

30576

Description

A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00490646

Lien

https://clinicaltrials.gov/show/NCT00490646

Mots-clés

Versions (1)
  1. 16/06/2018 16/06/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

16 juin 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Metastatic Breast Cancer NCT00490646

Anglais

Eligibility Metastatic Breast Cancer NCT00490646

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
locally advanced or metastatic her2+ breast cancer not previously treated with chemotherapy or trastuzumab.
Description

Locally advanced breast cancer | Secondary malignant neoplasm of female breast HER2 Positive | Chemotherapy Absent | Trastuzumab Absent

Type de données

boolean

Alias
UMLS CUI [1]
C3495949
UMLS CUI [2,1]
C0346993
UMLS CUI [2,2]
C2348909
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0728747
UMLS CUI [4,2]
C0332197
subjects who had received prior (neo)adjuvant chemotherapy or trastuzumab were eligible except if they relapsed within 12 months after the last dose of a taxane or trastuzumab given as (neo)adjuvant therapy.
Description

Chemotherapy, Adjuvant | Chemotherapy Neoadjuvant | Trastuzumab Adjuvant | Trastuzumab Neoadjuvant | Exception Recurrent disease Post Taxane | Exception Recurrent disease Post Trastuzumab

Type de données

boolean

Alias
UMLS CUI [1]
C0085533
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0600558
UMLS CUI [3,1]
C0728747
UMLS CUI [3,2]
C1522673
UMLS CUI [4,1]
C0728747
UMLS CUI [4,2]
C0600558
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0277556
UMLS CUI [5,3]
C0687676
UMLS CUI [5,4]
C0215136
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0277556
UMLS CUI [6,3]
C0687676
UMLS CUI [6,4]
C0728747
measurable disease
Description

Measurable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
left ventricular ejection fraction (lvef) ≥50%
Description

Left ventricular ejection fraction

Type de données

boolean

Alias
UMLS CUI [1]
C0428772
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy or trastuzumab for metastatic breast cancer (mbc)
Description

Chemotherapy Secondary malignant neoplasm of female breast | Trastuzumab Secondary malignant neoplasm of female breast

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0346993
UMLS CUI [2,1]
C0728747
UMLS CUI [2,2]
C0346993
relapse within 1 year after (neo)adjuvant taxane or trastuzumab
Description

Recurrent disease | Status post Taxane Adjuvant | Status post Taxane Neoadjuvant | Status post Trastuzumab Adjuvant | Status post Trastuzumab Neoadjuvant

Type de données

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0215136
UMLS CUI [2,3]
C1522673
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0215136
UMLS CUI [3,3]
C0600558
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C0728747
UMLS CUI [4,3]
C1522673
UMLS CUI [5,1]
C0231290
UMLS CUI [5,2]
C0728747
UMLS CUI [5,3]
C0600558
neuropathy > grade 1
Description

Neuropathy CTCAE Grades

Type de données

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C1516728
significant cardiovascular disease
Description

Cardiovascular Diseases

Type de données

boolean

Alias
UMLS CUI [1]
C0007222
any brain metastases
Description

Metastatic malignant neoplasm to brain

Type de données

boolean

Alias
UMLS CUI [1]
C0220650
Retour au début de la page

Similar models

Eligibility Metastatic Breast Cancer NCT00490646

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Locally advanced breast cancer | Secondary malignant neoplasm of female breast HER2 Positive | Chemotherapy Absent | Trastuzumab Absent
Item
locally advanced or metastatic her2+ breast cancer not previously treated with chemotherapy or trastuzumab.
boolean
C3495949 (UMLS CUI [1])
C0346993 (UMLS CUI [2,1])
C2348909 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0728747 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Chemotherapy, Adjuvant | Chemotherapy Neoadjuvant | Trastuzumab Adjuvant | Trastuzumab Neoadjuvant | Exception Recurrent disease Post Taxane | Exception Recurrent disease Post Trastuzumab
Item
subjects who had received prior (neo)adjuvant chemotherapy or trastuzumab were eligible except if they relapsed within 12 months after the last dose of a taxane or trastuzumab given as (neo)adjuvant therapy.
boolean
C0085533 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C0728747 (UMLS CUI [3,1])
C1522673 (UMLS CUI [3,2])
C0728747 (UMLS CUI [4,1])
C0600558 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0277556 (UMLS CUI [5,2])
C0687676 (UMLS CUI [5,3])
C0215136 (UMLS CUI [5,4])
C1705847 (UMLS CUI [6,1])
C0277556 (UMLS CUI [6,2])
C0687676 (UMLS CUI [6,3])
C0728747 (UMLS CUI [6,4])
Measurable Disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
Left ventricular ejection fraction
Item
left ventricular ejection fraction (lvef) ≥50%
boolean
C0428772 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Secondary malignant neoplasm of female breast | Trastuzumab Secondary malignant neoplasm of female breast
Item
prior chemotherapy or trastuzumab for metastatic breast cancer (mbc)
boolean
C0392920 (UMLS CUI [1,1])
C0346993 (UMLS CUI [1,2])
C0728747 (UMLS CUI [2,1])
C0346993 (UMLS CUI [2,2])
Recurrent disease | Status post Taxane Adjuvant | Status post Taxane Neoadjuvant | Status post Trastuzumab Adjuvant | Status post Trastuzumab Neoadjuvant
Item
relapse within 1 year after (neo)adjuvant taxane or trastuzumab
boolean
C0277556 (UMLS CUI [1])
C0231290 (UMLS CUI [2,1])
C0215136 (UMLS CUI [2,2])
C1522673 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C0215136 (UMLS CUI [3,2])
C0600558 (UMLS CUI [3,3])
C0231290 (UMLS CUI [4,1])
C0728747 (UMLS CUI [4,2])
C1522673 (UMLS CUI [4,3])
C0231290 (UMLS CUI [5,1])
C0728747 (UMLS CUI [5,2])
C0600558 (UMLS CUI [5,3])
Neuropathy CTCAE Grades
Item
neuropathy > grade 1
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Cardiovascular Diseases
Item
significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
any brain metastases
boolean
C0220650 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial